Senior MSL – Field Medical Affairs (Hematology)

Regeneron Pharmaceuticals; United States; A distancia; USD 176.000 - 287.000; Jornada completa

Descripción de la vacante

Regeneron Pharmaceuticals is seeking an Associate Director, Field Medical Affairs (Medical Science Liaison) to engage with KOLs, HCPs, researchers and decision makers on our B-Cell Malignancies programs.

The role focuses on scientific exchange, building relationships in Hematology/Oncology, and supporting investigator-initiated studies while working in the field with frequent travel (approx. 70%).

Formación

• Terminal scientific degree required.
• 8+ years experience, min 4 years in Hematology/Oncology MSL.
• Knowledge of guidelines, FDA pharma regulations, OIG.
• Residency in territory and valid driver’s license.
• KOLs & institutions relationships; drug launch experience preferred.

Responsabilidades

• Identify and manage medical/therapeutic area targets and action plans.
• Build and maintain relationships with KOLs in hematologic malignancies.
• Serve as the primary clinical/scientific resource for disease state and products.
• Support investigator-initiated studies and clinical trials.
• Identify insights on research developments to shape medical strategy.
• Respond to information requests and present clinical data.
• Attend medical conferences to gather and report scientific/clinical intelligence.
• Ensure policies and financial controls are maintained with integrity.

Conocimientos

KOL relationship mgmt

Medical science liaison

Hematology/Onc knowledge

Clinical data interpretation

Educación

MD/PhD/PharmD/DNP/DVM

Descripción del empleo

Regeneron Pharmaceuticals is seeking an Associate Director, Field Medical Affairs (Medical Science Liaison) to engage with KOLs, HCPs, researchers and decision makers on our B-Cell Malignancies programs.

The role focuses on scientific exchange, building relationships in Hematology/Oncology, and supporting investigator-initiated studies while working in the field with frequent travel (approx. 70%).